gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · NXGLHealthcareSurgical Instruments

NexGel, Inc Common Stock (NXGL)

$4.01−10.49%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$4.01▼ 90.89% in range
Nov 4, 2025Low $3.00 · High $80.12Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

NexGel closed at $4.01 on Nov 4, down 10.49%, 95.0% below its 52-week closing high. Volume of 45.2K shares was 0.13× its 20-day average (below normal).

Split-adjusted performance: +16.0% over one month, -66.6% over six months, -91.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $3.69M, up 27.8% from a year earlier, with a net margin of -98.6%.

Short interest was 104.7K shares at the Oct 15 settlement, down 67.5% from the prior report (1.3% of float, 1.0 days to cover).

Market cap$2.0M487.4K shares
Revenue · quarter$3.7M+27.8% YoY
Diluted EPS$-8.00—
P/E · TTM—P/S 0.2×
Net margin-98.6%Gross 30.1%
Dividend yieldNone
52-week range3.00 – 80.12−95.0% from high
Volume45.2K0.13× 20-day avg
Volatility · 60d934.9%Annualised
Short % of float1.3%1.0 days to cover
Net cash-$2.9MCash $492.0K
Next earnings—Not scheduled
Split-adjusted performance
1W −0.5%1M +16.0%3M −40.9%6M −66.6%YTD −87.5%1Y −91.5%3Y −87.5%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum14
Revenue growth84
Net margin24
Value (low P/E)—
Size2

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short104.7K−67.5% vs prior
Days to cover1.0Settled Oct 15
% of float1.3%
Short vol. 10d44.5%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
NXGLNexGel$4.01−10.49%−66.6%+27.8%−98.6%—$2.0M
VVOSVivos Therapeutics$0.1112+1.27%−84.6%+34.9%−106.4%—$2.2MCompare
XAIRBeyond Air$2.33+0.43%−79.4%+0.5%−448.8%—$2.3MCompare
IVFINVO Fertility$2.05+5.67%−71.7%+16.7%40.9%—$2.4MCompare
ADGMAdagio Medical Holdings$0.08620.00%−91.1%———$2.4MCompare
BJDXBluejay Diagnostics$2.29+3.62%−69.7%———$2.6MCompare
AMIXAutonomix Medical$1.61−3.01%−80.1%———$3.2MCompare
CODXCo-Diagnostics$0.3614−4.89%—+2.0%−3782.4%—$3.2MCompare
VJETFlyte Aviation$0.5600−4.76%————$1.2MCompare

News about NexGel

All news →
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ETGlobeNewswire Inc. · Apr 17, 2026NeutralEXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple RevenueBenzinga · Mar 10, 2026▲ Positive

Quick answers

What does NexGel do?
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies.
What is NXGL's market cap?
$1.95M, based on the Nov 4 close of $4.01.
Does NexGel pay a dividend?
No regular cash dividend has been paid in the last year.
How much of NXGL is sold short?
104.7K shares, 1.3% of float, as of Oct 15, 2026.
What sector is NXGL in?
Healthcare, in the Surgical Instruments industry.

About NexGel

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

HQ: Langhorne, PA19 employeesListed Dec 22, 2021nexgel.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology